IGM Biosciences to Present at the 2024 RBCCM Global Healthcare Conference
May 07, 2024 07:00 ET
|
IGM Biosciences, Inc.
MOUNTAIN VIEW, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today...
Cipher Mining Provides First Quarter 2024 Business Update
May 07, 2024 07:00 ET
|
Cipher Mining Inc.
First Quarter 2024 GAAP Net Income of $40m, and Non-GAAP Adjusted Earnings of $63m First Quarter 2024 Revenues of $48m Current Self-Mining Hash Rate of ~7.7 EH/s and on track to reach ~9.3 EH/s by...
Red Cat Launches Robotics and Autonomous Systems Consortium to Bridge Critical UAS Technology Gaps for Warfighters
May 07, 2024 07:00 ET
|
Red Cat Holdings, Inc.
SAN JUAN, Puerto Rico, May 07, 2024 (GLOBE NEWSWIRE) -- Red Cat Holdings, Inc. (Nasdaq: RCAT) (“Red Cat”), a drone technology company integrating robotic hardware and software for military,...
Nurix Therapeutics to Participate in RBC Capital Markets Global Healthcare Conference
May 07, 2024 07:00 ET
|
Nurix Therapeutics, Inc.
SAN FRANCISCO, May 07, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein modulation drugs designed to treat...
Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
May 07, 2024 07:00 ET
|
Neumora Therapeutics, Inc.
On-track to report topline Phase 3 data from KOASTAL-1 study with navacaprant in MDD; guidance narrowed to fourth quarter of 2024 Multiple clinical study initiations planned in second quarter of...
SOPHiA GENETICS Reports First Quarter 2024 Results
May 07, 2024 06:45 ET
|
SOPHiA GENETICS, Inc.
BOSTON and ROLLE, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, today reported financial results...
Descartes’ Annual Ecommerce Study Shows Online Buying Grows but 67% of Consumers Face Delivery Problems
May 07, 2024 06:45 ET
|
The Descartes Systems Group Inc.
ATLANTA and LONDON, May 07, 2024 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq: DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, released findings from...
Cellectar Biosciences to Announce First Quarter Financial Results and Host a Conference Call on Tuesday, May 14, 2024
May 07, 2024 06:40 ET
|
Cellectar Biosciences
FLORHAM PARK, N.J., May 07, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and...
Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
May 07, 2024 06:30 ET
|
Design Therapeutics, Inc.
CARLSBAD, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a biotechnology company developing treatments for serious degenerative genetic diseases, today announced...
Beam Therapeutics Reports Pipeline Updates and First Quarter 2024 Financial Results
May 07, 2024 06:30 ET
|
Beam Therapeutics
Dosing Completed for Sentinel Cohort of BEACON Phase 1/2 Trial of BEAM-101 in Severe Sickle Cell Disease; Expansion Cohort Initiated Clinical Trial Authorisation (CTA) Application Cleared for the...